Technical Analysis for BLFS - BioLife Solutions, Inc.

Grade Last Price % Change Price Change
B 21.96 -0.05% -0.01
BLFS closed down 0.05 percent on Friday, May 17, 2024, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Evening Star Bearish -0.05%
Slingshot Bullish Bullish Swing Setup -0.05%
Upper Bollinger Band Walk Strength -0.05%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioLife Solutions, Inc. Description

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company’s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it’s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Life Sciences Pharmaceutical Biology Drug Discovery Stem Cell Cell Biology Regenerative Medicine Packaging Products Toxicology Organs Blood Adult Stem Cell Childbirth Media Products Cord Blood Organ Transplantation Packaging Services Toxicology Testing Cryopreservation

Is BLFS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.5
52 Week Low 8.9201
Average Volume 424,013
200-Day Moving Average 15.23
50-Day Moving Average 17.91
20-Day Moving Average 18.84
10-Day Moving Average 20.23
Average True Range 1.14
RSI (14) 69.42
ADX 25.37
+DI 34.28
-DI 13.40
Chandelier Exit (Long, 3 ATRs) 19.67
Chandelier Exit (Short, 3 ATRs) 18.27
Upper Bollinger Bands 22.76
Lower Bollinger Band 14.91
Percent B (%b) 0.9
BandWidth 41.65
MACD Line 1.26
MACD Signal Line 0.77
MACD Histogram 0.4884
Fundamentals Value
Market Cap 989.24 Million
Num Shares 45 Million
EPS -2.37
Price-to-Earnings (P/E) Ratio -9.27
Price-to-Sales 5.48
Price-to-Book 2.53
PEG Ratio 63.20
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.68
Resistance 3 (R3) 22.65 22.38 22.56
Resistance 2 (R2) 22.38 22.20 22.40 22.52
Resistance 1 (R1) 22.17 22.08 22.04 22.20 22.48
Pivot Point 21.90 21.90 21.83 21.92 21.90
Support 1 (S1) 21.69 21.72 21.56 21.72 21.44
Support 2 (S2) 21.42 21.60 21.44 21.40
Support 3 (S3) 21.21 21.42 21.36
Support 4 (S4) 21.24